Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.14% | 148.74 | 0.7% | $978.30m | |
| PFE | Pfizer Inc. | 1.41% | 36.68 | 0.9% | $849.67m | |
| MRK | Merck & Co., Inc. | 1.21% | 82.89 | 0.7% | $707.24m | |
| ABBV | AbbVie, Inc. | 0.71% | 87.51 | 1.9% | $686.32m | |
| BMY | Bristol-Myers Squibb Co. | 0.63% | 60.28 | 1.0% | $649.30m | |
| LLY | Eli Lilly & Co. | 1.22% | 148.04 | 1.1% | $562.19m | |
| AZN | AstraZeneca Plc | -0.56% | 54.80 | 1.2% | $253.82m | |
| NVS | Novartis AG | -0.10% | 86.95 | 0.2% | $174.03m | |
| GSK | GlaxoSmithKline Plc | 0.61% | 37.66 | 0.2% | $114.15m | |
| NVO | Novo Nordisk A/S | -1.13% | 69.43 | 0.1% | $63.36m | |
| RGEN | Repligen Corp. | -2.03% | 147.54 | 7.1% | $49.79m | |
| RPRX | Royalty Pharma Plc | 0.14% | 42.07 | 0.2% | $48.05m | |
| SNY | Sanofi | -0.65% | 50.17 | 0.2% | $45.36m | |
| OPK | OPKO Health, Inc. | 7.58% | 3.69 | 11.2% | $41.04m | |
| TPTX | Turning Point Therapeutics, Inc. | -1.34% | 87.36 | 0.0% | $36.11m |
Company Profile
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.